Literature DB >> 31100553

Cross-reactivity and tolerability of celecoxib in adult patients with NSAID hypersensitivity.

Lily Li1, Tanya Laidlaw2.   

Abstract

Entities:  

Year:  2019        PMID： 31100553      PMCID： PMC7328117          DOI： 10.1016/j.jaip.2019.04.042

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


× No keyword cloud information.
  9 in total

1.  Asthma attacks induced by low doses of celecoxib, aspirin, and acetaminophen.

Authors:  Sandra Baldassarre; Liliane Schandene; Georges Choufani; Alain Michils
Journal:  J Allergy Clin Immunol       Date:  2006-01       Impact factor: 10.793

2.  Different eicosanoid profile of the hypersensitivity reactions triggered by aspirin and celecoxib in a patient with sinusitis, asthma, and urticaria.

Authors:  Lucyna Mastalerz; Marek Sanak; Agnieszka Gawlewicz; Anna Gielicz; Jacek Faber; Andrew Szczeklik
Journal:  J Allergy Clin Immunol       Date:  2006-08-24       Impact factor: 10.793

3.  Asthmatic reaction induced by celecoxib in a patient with aspirin-induced asthma.

Authors:  R Muñoz-Cano; J Bartra; M C Vennera; A Valero; C Picado
Journal:  J Investig Allergol Clin Immunol       Date:  2009       Impact factor: 4.333

4.  Selective cyclooxygenase-2 inhibitor cross-reactivity in aspirin-exacerbated respiratory disease.

Authors:  Junichi Umemoto; Naomi Tsurikisawa; Shinichi Nogi; Kanako Iwata; Chiyako Oshikata; Sayaka Tatsuno; Hidenori Tanimoto; Kiyoshi Sekiya; Takahiro Tsuburai; Hiroyuki Mitomi; Kazuo Akiyama
Journal:  Allergy Asthma Proc       Date:  2011 May-Jun       Impact factor: 2.587

Review 5.  Current Knowledge and Management of Hypersensitivity to Aspirin and NSAIDs.

Authors:  Tanya M Laidlaw; Katherine N Cahill
Journal:  J Allergy Clin Immunol Pract       Date:  2017 May - Jun

6.  Safety of a specific COX-2 inhibitor in aspirin-induced asthma.

Authors:  A Szczeklik; E Nizankowska; G Bochenek; K Nagraba; F Mejza; M Swierczynska
Journal:  Clin Exp Allergy       Date:  2001-02       Impact factor: 5.018

7.  Adverse and Hypersensitivity Reactions to Prescription Nonsteroidal Anti-Inflammatory Agents in a Large Health Care System.

Authors:  Kimberly G Blumenthal; Kenneth H Lai; Mingshu Huang; Zachary S Wallace; Paige G Wickner; Li Zhou
Journal:  J Allergy Clin Immunol Pract       Date:  2017-01-18

Review 8.  Epidemiology of hypersensitivity drug reactions.

Authors:  Eva Rebelo Gomes; Pascal Demoly
Journal:  Curr Opin Allergy Clin Immunol       Date:  2005-08

9.  Safety risks for patients with aspirin-exacerbated respiratory disease after acute exposure to selective nonsteroidal anti-inflammatory drugs and COX-2 inhibitors: Meta-analysis of controlled clinical trials.

Authors:  Daniel R Morales; Brian J Lipworth; Bruce Guthrie; Cathy Jackson; Peter T Donnan; Virginia H Santiago
Journal:  J Allergy Clin Immunol       Date:  2013-12-31       Impact factor: 10.793
  9 in total
  3 in total

1.  Clinical Characteristics, Urinary Leukotriene E4 Levels, and Aspirin Desensitization Results in Patients With NSAID-Induced Blended Reactions.

Authors:  Jettanong Klaewsongkram; Supranee Buranapraditkun; Pungjai Mongkolpathumrat; Sirinoot Palapinyo; Hiroshi Chantaphakul
Journal:  Allergy Asthma Immunol Res       Date:  2021-03       Impact factor: 5.764

2.  The importance of timely diagnosis of aspirin-exacerbated respiratory disease for patient health and safety.

Authors:  Kathleen Buchheit; Jillian C Bensko; Erin Lewis; Deborah Gakpo; Tanya M Laidlaw
Journal:  World J Otorhinolaryngol Head Neck Surg       Date:  2020-09-08

3.  Impact of reported NSAID "allergies" on opioid use disorder in back pain.

Authors:  Lily Li; Yuchiao Chang; Shuang Song; Elena Losina; Karen H Costenbader; Tanya M Laidlaw
Journal:  J Allergy Clin Immunol       Date:  2020-09-09       Impact factor: 10.793
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.